| (One intermediate revision by the same user not shown) | |||
| Line 71: | Line 71: | ||
='''Nicotine Pouches'''= | ='''Nicotine Pouches'''= | ||
===2024: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944327/ Tobacco-Free Nicotine Pouches and Their Potential Contribution to Tobacco Harm Reduction: A Scoping Review]=== | |||
*Based on the reviewed evidence, TFNPs contain significantly fewer and lower levels of harmful chemicals, have a reduced toxicological impact compared to cigarette smoke, and may convey lower health risks compared to smoking. | |||
*Citation: Grandolfo E, Ogden H, Fearon IM, Malt L, Stevenson M, Weaver S, Nahde T. Tobacco-Free Nicotine Pouches and Their Potential Contribution to Tobacco Harm Reduction: A Scoping Review. Cureus. 2024 Feb 15;16(2):e54228. doi: 10.7759/cureus.54228. PMID: 38496069; PMCID: PMC10944327. | |||
===2022: [https://f1000research.com/articles/9-1225#f1 Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations<nowiki>]</nowiki> Previously titled: Nicotine products relative risk assessment: a systematic review and meta-analysis]=== | ===2022: [https://f1000research.com/articles/9-1225#f1 Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations<nowiki>]</nowiki> Previously titled: Nicotine products relative risk assessment: a systematic review and meta-analysis]=== | ||
| Line 76: | Line 80: | ||
*Citation: Murkett R, Rugh M and Ding B. Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2022, 9:1225 (https://doi.org/10.12688/f1000research.26762.2) | *Citation: Murkett R, Rugh M and Ding B. Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2022, 9:1225 (https://doi.org/10.12688/f1000research.26762.2) | ||
<br> | <br> | ||
='''Nicotine Replacement Therapy (NRT)'''= | ='''Nicotine Replacement Therapy (NRT)'''= | ||
| Line 85: | Line 90: | ||
*There was moderate‐certainty that NRT reduced weight at end of treatment and moderate‐certainty that the effect may be similar at 12 months, although the estimates are too imprecise to assess long‐term benefit. | *There was moderate‐certainty that NRT reduced weight at end of treatment and moderate‐certainty that the effect may be similar at 12 months, although the estimates are too imprecise to assess long‐term benefit. | ||
*Citation: Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD006219. DOI: 10.1002/14651858.CD006219.pub4. Accessed 17 March 2024. | *Citation: Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD006219. DOI: 10.1002/14651858.CD006219.pub4. Accessed 17 March 2024. | ||
===2003: [https://tobaccocontrol.bmj.com/content/12/2/124 Estimating the health consequences of replacing cigarettes with nicotine inhalers]=== | |||
*Prevention of tobacco use is historically difficult in spite of clear health hazards. Regulatory responses to the problem are tenuous and subject to reversal or delay as political and economic fortunes change. A lasting reduction in tobacco related illness might result from unleashing clean alternative nicotine delivery systems to compete directly with tobacco products. Even if used very broadly, clean inhaled nicotine might reduce public health problems as much as a very successful tobacco control programme. | |||
*[https://sci-hub.wf/10.2307/20208116 PDF] | |||
*Citation: W. Sumner II (2003). Estimating the Health Consequences of Replacing Cigarettes with Nicotine Inhalers. Tobacco Control, 12(2), 124–132. doi:10.2307/20208116 | |||
<br> | <br> | ||
edits